Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 184.15
+2.10 (1.15%)
Mar 24, 2026, 5:24 PM CET
Getinge AB Market Cap
Getinge AB has a market cap or net worth of 49.58 billion as of March 24, 2026. Its market cap has decreased by -16.87% in one year.
Market Cap
49.58B
Enterprise Value
57.13B
Revenue
34.97B
Ranking
n/a
PE Ratio
21.96
Stock Price
184.15
Market Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 15.22B to 49.58B, an increase of 225.87%. That is a compound annual growth rate of 4.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 49.58B | -16.80% |
| Dec 30, 2025 | 59.59B | 20.52% |
| Dec 30, 2024 | 49.45B | -19.06% |
| Dec 29, 2023 | 61.09B | 3.70% |
| Dec 30, 2022 | 58.91B | -45.25% |
| Dec 30, 2021 | 107.61B | 105.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 42.77B |
| Elekta AB | 21.36B |
| Nolato AB | 12.74B |
| Vitrolife AB | 11.91B |
| MedCap AB | 6.86B |
| Xvivo Perfusion AB | 5.99B |
| CellaVision AB | 3.43B |
| BICO Group AB | 1.18B |